282 related articles for article (PubMed ID: 21406339)
1. Metal ions, Alzheimer's disease and chelation therapy.
Budimir A
Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
[TBL] [Abstract][Full Text] [Related]
2. Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics.
Duce JA; Bush AI
Prog Neurobiol; 2010 Sep; 92(1):1-18. PubMed ID: 20444428
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease, metal ions and metal homeostatic therapy.
Zatta P; Drago D; Bolognin S; Sensi SL
Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
[TBL] [Abstract][Full Text] [Related]
4. The relevance of metals in the pathophysiology of neurodegeneration, pathological considerations.
Jellinger KA
Int Rev Neurobiol; 2013; 110():1-47. PubMed ID: 24209432
[TBL] [Abstract][Full Text] [Related]
5. Metals ions and neurodegeneration.
Molina-Holgado F; Hider RC; Gaeta A; Williams R; Francis P
Biometals; 2007 Jun; 20(3-4):639-54. PubMed ID: 17294125
[TBL] [Abstract][Full Text] [Related]
6. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
7. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.
Gaeta A; Hider RC
Br J Pharmacol; 2005 Dec; 146(8):1041-59. PubMed ID: 16205720
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation.
Choi JS; Braymer JJ; Park SK; Mustafa S; Chae J; Lim MH
Metallomics; 2011 Mar; 3(3):284-91. PubMed ID: 21210061
[TBL] [Abstract][Full Text] [Related]
9. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
Zheng H; Youdim MB; Fridkin M
J Med Chem; 2009 Jul; 52(14):4095-8. PubMed ID: 19485411
[TBL] [Abstract][Full Text] [Related]
10. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
11. Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases.
Boldron C; Van der Auwera I; Deraeve C; Gornitzka H; Wera S; Pitié M; Van Leuven F; Meunier B
Chembiochem; 2005 Nov; 6(11):1976-80. PubMed ID: 16208731
[No Abstract] [Full Text] [Related]
12. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.
Liu G; Men P; Harris PL; Rolston RK; Perry G; Smith MA
Neurosci Lett; 2006 Oct; 406(3):189-93. PubMed ID: 16919875
[TBL] [Abstract][Full Text] [Related]
13. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.
Cui Z; Lockman PR; Atwood CS; Hsu CH; Gupte A; Allen DD; Mumper RJ
Eur J Pharm Biopharm; 2005 Feb; 59(2):263-72. PubMed ID: 15661498
[TBL] [Abstract][Full Text] [Related]
14. Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.
Zheng H; Youdim MB; Fridkin M
ACS Chem Biol; 2010 Jun; 5(6):603-10. PubMed ID: 20455574
[TBL] [Abstract][Full Text] [Related]
15. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
16. Metal attenuating therapies in neurodegenerative disease.
Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyquinoline based binders: promising ligands for chelatotherapy?
Budimir A; Humbert N; Elhabiri M; Osinska I; Biruš M; Albrecht-Gary AM
J Inorg Biochem; 2011 Mar; 105(3):490-6. PubMed ID: 20926137
[TBL] [Abstract][Full Text] [Related]
18. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
Robert A; Liu Y; Nguyen M; Meunier B
Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
[TBL] [Abstract][Full Text] [Related]
19. Unusual Cyclodextrin Derivatives as a New Avenue to Modulate Self- and Metal-Induced Aβ Aggregation.
Oliveri V; Bellia F; Pietropaolo A; Vecchio G
Chemistry; 2015 Sep; 21(40):14047-59. PubMed ID: 26298549
[TBL] [Abstract][Full Text] [Related]
20. Chelating agents for neurodegenerative diseases.
Ward RJ; Dexter DT; Crichton RR
Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
